FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to medicine, namely to an oral pharmaceutical composition in the form of single doses, containing a combination of entacapone, levodopa and carbidopa, or salts thereof with one or more sugar alcohols; wherein entacapone is micronised together with one or more sugar alcohols, and a mixture of micronised entacapone and sugar alcohol prepared thereby has an average particle size less than 30 mcm.
EFFECT: invention enables higher dissolution rate in an aqueous media, absorption and bioavailability.
10 cl, 4 tbl, 1 ex
Authors
Dates
2013-06-27—Published
2009-02-06—Filed